Operating Cash Flow (Statement)

$835.00M

Quarterly · Period ending: Jun 28, 2026 · USD

Latest reported$835.00Mperiod endingJun 28, 2026

PFE Quarterly Cash from Operations ($112.00M → $835.00M)

Quarterly operating cash flow (statement)

High-resolution chart · PNG

PFE operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Operating Cash Flow (Statement) — Quarterly (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jul 1, 2001	2,396,000,000
Apr 1, 2001	1,814,000,000
Dec 31, 2000	2,650,000,000
Oct 1, 2000	2,123,000,000
Jul 2, 2000	358,000,000
Apr 2, 2000	1,064,000,000
Dec 31, 1999	1,278,000,000
Oct 3, 1999	1,164,000,000
Jul 4, 1999	738,000,000
Apr 4, 1999	-124,000,000
Dec 31, 1998	1,395,000,000
Sep 27, 1998	808,000,000
Jun 28, 1998	618,000,000
Mar 29, 1998	108,000,000
Dec 31, 1997	468,000,000
Sep 28, 1997	484,000,000
Jun 29, 1997	410,000,000
Mar 30, 1997	267,000,000
Dec 31, 1996	755,000,000
Sep 29, 1996	589,000,000
Jun 30, 1996	502,000,000
Mar 31, 1996	221,000,000
Dec 31, 1995	654,800,000
Oct 1, 1995	417,600,000
Jul 2, 1995	191,200,000
Apr 2, 1995	557,800,000
Dec 31, 1994	481,200,000
Oct 2, 1994	404,500,000
Jul 3, 1994	357,500,000
Apr 3, 1994	245,300,000
Dec 31, 1993	680,100,000
Sep 30, 1993	321,600,000
Jun 30, 1993	229,800,000
Mar 31, 1993	31,500,000
Dec 31, 1992	353,200,000
Sep 30, 1992	259,100,000
Jun 30, 1992	170,600,000
Mar 31, 1992	24,100,000
Dec 31, 1991	367,600,000
Sep 30, 1991	171,700,000
Jun 30, 1991	231,400,000
Mar 31, 1991	76,900,000
Dec 31, 1990	403,500,000
Sep 30, 1990	128,300,000
Jun 30, 1990	216,700,000
Mar 31, 1990	112,000,000